Abstract
Objective: The aim of this study was to assess survival outcomes of weekly paclitaxel plus carboplatin every 3 weeks (dose dense regimen) compared to the standard 3-week protocol in the adjuvant setting for endometrial cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
